株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

腹部肥満症:世界の治験レビュー

Abdominal Obesity Global Clinical Trials Review, H1, 2017

発行 GlobalData 商品コード 301444
出版日 ページ情報 英文 79 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.35円で換算しております。
Back to Top
腹部肥満症:世界の治験レビュー Abdominal Obesity Global Clinical Trials Review, H1, 2017
出版日: 2017年02月22日 ページ情報: 英文 79 Pages
概要

当レポートでは、腹部肥満症の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどを提供して、概略以下の構成でお届けいたします。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験:代謝障害の治験に対する腹部肥満症の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:代謝障害の治験に対する腹部肥満症の割合

E7諸国における治験:相別

E7諸国における治験:段階別

相別の治験

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • 腹部肥満症の治療薬の治験に参加している主要企業

有望薬

最新の治験ニュース

治験プロファイル

  • 主要企業の治験概要
    • Genfit
    • Lithera, Inc.
    • AstraZeneca PLC
    • Sanofi
    • Novartis AG
    • Hanmi Science Co., Ltd.
    • Parry Nutraceuticals
    • Kythera Biopharmaceuticals, Inc.
    • Johnson & Johnson
  • 主要大学・研究機関・病院の治験概要
    • Queen's University
    • Massachusetts General Hospital
    • University of Pittsburgh
    • Wake Forest University
    • Baker IDI Heart and Diabetes Institute
    • Rush University Medical Center
    • UMC Utrecht Holding BV
    • Southeast University
    • Washington University School of Medicine
    • Maastricht University Medical Center

主な臨床プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Abdominal Obesity Global Clinical Trials Review, H1, 2017" provides an overview of Abdominal Obesity clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Obesity. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • Clinical Trials by Region 5
  • Clinical Trials and Average Enrollment by Country 6
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8
  • Top Five Countries Contributing to Clinical Trials in Europe 9
  • Top Countries Contributing to Clinical Trials in North America 10
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 11
  • Top Countries Contributing to Clinical Trials in Central and South America 12
  • Clinical Trials by G7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by E7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials 16
  • Clinical Trials by Phase in E7 Countries 17
  • Clinical Trials in E7 Countries by Trial Status 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Abdominal Obesity Therapeutics Clinical Trials 26
  • Prominent Drugs 27
  • Latest Clinical Trials News on Abdominal Obesity 28
  • Dec 23, 2016: Neothetics Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat 28
  • Clinical Trial Profile Snapshots 29

Appendix 76

  • Abbreviations 76
  • Definitions 76
  • Research Methodology 77
  • Secondary Research 77
  • About GlobalData 78
  • Contact Us 78
  • Disclaimer 78
  • Source 79

List of Tables

List of Tables

  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Region, 2017* 5
  • Abdominal Obesity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
  • Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7
  • Abdominal Obesity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 8
  • Abdominal Obesity Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 9
  • Abdominal Obesity Therapeutics Clinical Trials, North America, Top Countries, 2017* 10
  • Abdominal Obesity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 11
  • Abdominal Obesity Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 12
  • Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 13
  • Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 16
  • Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
  • Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Phase, 2017* 19
  • Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Abdominal Obesity Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Abdominal Obesity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

List of Figures

List of Figures

  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Region (%), 2017* 5
  • Abdominal Obesity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
  • Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7
  • Abdominal Obesity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 8
  • Abdominal Obesity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 9
  • Abdominal Obesity Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 10
  • Abdominal Obesity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 11
  • Abdominal Obesity Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 12
  • Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 13
  • Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 16
  • Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
  • Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
  • Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Abdominal Obesity Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Abdominal Obesity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27
  • GlobalData Methodology 77
Back to Top